Compositions and methods for effecting controlled posterior...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) A61K 31/573 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2643282

A composition comprises plasmin or an enzymatically equivalent derivative thereof and at least an anti-inflammatory medicament, such as triamcinolone acetonide. The composition can be used to effect or induce a controlled posterior vitreous detachment ("PVD") to prevent, treat, or ameliorate a potential complication of a pathological ocular condition. Such a composition can be administered intravitreally.

L'invention concerne une composition comprend de la plasmine ou un dérivé de celle-ci enzymatiquement équivalent, et au moins un médicament anti-inflammatoire. La composition peut être utilisée pour pratiquer ou induire un détachement vitreux postérieur (DVP) contrôlé afin de prévenir, de traiter, ou d'améliorer une complication potentielle d'une condition oculaire pathologique. Une telle composition peut être administrée intravitréennement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for effecting controlled posterior... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for effecting controlled posterior..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for effecting controlled posterior... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1682239

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.